[Chemotherapy program for treatment of Hodgkin's disease refractory to MOPP or MVPP].
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008722:Methods; D011241:Prednisone / Q000008:administration & dosage; D012075:Remission, Spontaneous; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D001761:Bleomycin; D014750:Vincristine; D014747:Vinblastine; D004317:Doxorubicin; D011241:Prednisone
Programy chemioterapii w ziarnicy złośliwej opornej na MOPP lub MVPP.